APOE and neuroblastoma: In order to better define the subcellular localization of ApoE, N2a neuroblastoma cells were initially treated with physiological levels (2.5 μg/ml) of recombinant human ApoE3 or ApoE4 for 15 min and 4 h (Fig 1A).